{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:01:43Z","timestamp":1793055703066,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["255989"],"award-info":[{"award-number":["255989"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008222","name":"Universit\u00e9 de Montpellier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-148413"],"award-info":[{"award-number":["FDN-148413"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MFE-164740"],"award-info":[{"award-number":["MFE-164740"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010977","name":"Cognitive Neuroscience Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009874","name":"Universit\u00e9 de Sherbrooke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.bbr.2021.113189","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T04:31:32Z","timestamp":1613536292000},"page":"113189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia"],"prefix":"10.1016","volume":"405","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7208-9858","authenticated-orcid":false,"given":"M\u00e9lanie","family":"Vivancos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7473-7043","authenticated-orcid":false,"given":"\u00c9lie","family":"Besserer-Offroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-8417","authenticated-orcid":false,"given":"Sabrina","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Chartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Resua-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Mona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santo","family":"Previti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"R\u00e9mond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3985-2318","authenticated-orcid":false,"given":"Jean-Michel","family":"Longpr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-6416","authenticated-orcid":false,"given":"Florine","family":"Cavelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7627-701X","authenticated-orcid":false,"given":"Philippe","family":"Sarret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2021.113189_bib0005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/1471-2458-11-770","article-title":"Pain as a global public health priority","volume":"11","author":"Goldberg","year":"2011","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.bbr.2021.113189_bib0010","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1213\/ANE.0b013e3181cde882","article-title":"The development of new analgesics over the past 50 years: a lack of real breakthrough drugs","volume":"110","author":"Kissin","year":"2010","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.bbr.2021.113189_bib0015","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2012.11.011","article-title":"Opioids for chronic pain: new evidence, new strategies, safe prescribing","author":"de Leon-Casasola","year":"2013","journal-title":"Am. J. Med."},{"issue":"9","key":"10.1016\/j.bbr.2021.113189_bib0020","first-page":"826","article-title":"Trends in high-dose opioid prescribing in Canada","volume":"60","author":"Gomes","year":"2014","journal-title":"Can. Fam. Phys."},{"key":"10.1016\/j.bbr.2021.113189_bib0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7812\/TPP\/16-169","article-title":"Physician guide to appropriate opioid prescribing for noncancer pain","volume":"21","author":"Munzing","year":"2017","journal-title":"Perm. J."},{"issue":"2","key":"10.1016\/j.bbr.2021.113189_bib0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3166\/dea-2019-0065","article-title":"Sending out biased signals: an appropriate proposition for pain?","volume":"32","author":"Besserer-Offroy","year":"2019","journal-title":"Douleur et Analg\u00e9sie"},{"key":"10.1016\/j.bbr.2021.113189_bib0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.abb.2018.10.011","article-title":"Recent progress in non-opioid analgesic peptides","volume":"660","author":"Perez de Vega","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"17\u201318","key":"10.1016\/j.bbr.2021.113189_bib0045","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","article-title":"Future directions for peptide therapeutics development","volume":"18","author":"Kaspar","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbr.2021.113189_bib0050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bcp.2011.10.014","article-title":"Peptide therapeutics for CNS indications","author":"McGonigle","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbr.2021.113189_bib0055","series-title":"Neurotensin and Its Receptors, Reference Module in Neuroscience and Biobehavioral Psychology","first-page":"1","author":"Sarret","year":"2018"},{"issue":"19","key":"10.1016\/j.bbr.2021.113189_bib0060","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1016\/S0021-9258(19)43429-7","article-title":"The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami","volume":"248","author":"Carraway","year":"1973","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bbr.2021.113189_bib0065","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0165-6147(99)01357-7","article-title":"Neurotensin and neurotensin receptors","volume":"20","author":"Vincent","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbr.2021.113189_bib0070","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejphar.2015.05.025","article-title":"Emerging role of neurotensin in regulation of the cardiovascular system","volume":"762","author":"Osadchii","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2021.113189_bib0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(81)90469-6","article-title":"The hypotensive effect of centrally administered neurotensin in rats","volume":"69","author":"Rioux","year":"1981","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbr.2021.113189_bib0080","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1210\/en.2016-1542","article-title":"Elucidating the role of peripheral neurotensin in appetite control","volume":"157","author":"Izaguirre","year":"2016","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.bbr.2021.113189_bib0085","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.peptides.2005.12.016","article-title":"Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation","volume":"27","author":"Zhao","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.bbr.2021.113189_bib0090","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.bbr.2014.10.021","article-title":"Positive reinforcing effect of neurotensin microinjection into the ventral pallidum in conditioned place preference test","volume":"278","author":"Ollmann","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.bbr.2021.113189_bib0095","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1471-4159.2011.07472.x","article-title":"Beta-Lactotensin derived from bovine beta-lactoglobulin exhibits anxiolytic-like activity as an agonist for neurotensin NTS(2) receptor via activation of dopamine D(1) receptor in mice","volume":"119","author":"Hou","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2021.113189_bib0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fendo.2013.00036","article-title":"Diverse roles of neurotensin agonists in the central nervous system","volume":"4","author":"Boules","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.bbr.2021.113189_bib0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1139\/jpn.0627","article-title":"The role of neurotensin in central nervous system pathophysiology: what is the evidence?","volume":"31","author":"St-Gelais","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"issue":"7","key":"10.1016\/j.bbr.2021.113189_bib0110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2174\/1389203715666140901105253","article-title":"Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson\u2019s disease and schizophrenia","volume":"15","author":"Ferraro","year":"2014","journal-title":"Curr. Protein Pept. Sci."},{"issue":"5569","key":"10.1016\/j.bbr.2021.113189_bib0115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/262607a0","article-title":"Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin","volume":"262","author":"Bissette","year":"1976","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbr.2021.113189_bib0120","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2174\/1381612820666141027124915","article-title":"The roles of neurotensin and its analogues in pain","volume":"21","author":"Feng","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"10.1016\/j.bbr.2021.113189_bib0125","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.peptides.2006.04.025","article-title":"Neurotensin and pain modulation","volume":"27","author":"Dobner","year":"2006","journal-title":"Peptides"},{"issue":"1\u20133","key":"10.1016\/j.bbr.2021.113189_bib0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2013.03.004","article-title":"Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation--a review","volume":"716","author":"Kleczkowska","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"39","key":"10.1016\/j.bbr.2021.113189_bib0135","doi-asserted-by":"crossref","first-page":"36233","DOI":"10.1074\/jbc.M202586200","article-title":"Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells","volume":"277","author":"Sarret","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2021.113189_bib0140","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-5-38","article-title":"Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity","author":"Roussy","year":"2009","journal-title":"Mol. Pain"},{"key":"10.1016\/j.bbr.2021.113189_bib0145","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1471-4159.2007.05205.x","article-title":"Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model","author":"Roussy","year":"2008","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.bbr.2021.113189_bib0150","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0014-2999(77)90236-9","article-title":"Neurotensin administered intracisternally inhibits responsiveness of mice to noxious stimuli","volume":"46","author":"Clineschmidt","year":"1977","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1432-1033.1982.tb05913.x","article-title":"Synthesis and characterization of neurotensin analogues for structure\/activity relationship studies. Acetyl-neurotensin-(8--13) is the shortest analogue with full binding and pharmacological activities","volume":"124","author":"Granier","year":"1982","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbr.2021.113189_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2017.03.046","article-title":"The signaling signature of the neurotensin type 1 receptor with endogenous ligands","author":"Besserer-Offroy","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2009.07.001","article-title":"The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperature","volume":"58","author":"Feifel","year":"2010","journal-title":"Neuropharmacology"},{"issue":"36","key":"10.1016\/j.bbr.2021.113189_bib0170","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1523\/JNEUROSCI.0810-05.2005","article-title":"Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors","volume":"25","author":"Sarret","year":"2005","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2021.113189_bib0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pain.2007.06.010","article-title":"Neurotensin-produced antinociception in the rostral ventromedial medulla is partially mediated by spinal cord norepinephrine","volume":"135","author":"Buhler","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.bbr.2021.113189_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173174","article-title":"Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog","author":"T\u00e9treault","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.bbr.2021.113189_bib0185","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1021\/acs.jmedchem.8b00175","article-title":"Structural optimization and characterization of potent analgesic macrocyclic analogues of neurotensin (8-13)","volume":"61","author":"Sousbie","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2021.113189_bib0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0006-8993(02)03271-7","article-title":"Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia","volume":"953","author":"Remaury","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2021.113189_bib0195","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.00406","article-title":"Insightful backbone modifications preventing proteolytic degradation of neurotensin analogs improve NTS1-Induced protective hypothermia","volume":"8","author":"Previti","year":"2020","journal-title":"Front. Chem."},{"issue":"3","key":"10.1016\/j.bbr.2021.113189_bib0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1021\/acsmedchemlett.7b00500","article-title":"In search of the optimal macrocyclization site for neurotensin","volume":"9","author":"Sousbie","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.bbr.2021.113189_bib0205","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbr.2021.113189_bib0210","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ejoc.201501495","article-title":"Stereoselective synthesis of \u03b2-(5-Arylthiazolyl) \u03b1-amino acids and use in neurotensin analogues","volume":"2016","author":"Hap\u0103u","year":"2016","journal-title":"European J. Org. Chem."},{"issue":"7","key":"10.1016\/j.bbr.2021.113189_bib0215","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2021.113189_bib0220","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroscience.2009.03.053","article-title":"Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents","volume":"161","author":"Beaudry","year":"2009","journal-title":"Neuroscience"},{"issue":"2\u20133","key":"10.1016\/j.bbr.2021.113189_bib0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-2999(91)90097-A","article-title":"Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation\/hyperalgesia: possible involvement of noradrenergic mechanisms","volume":"194","author":"Hylden","year":"1991","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bbr.2021.113189_bib0230","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0169-409X(03)00101-7","article-title":"Spinal delivery of analgesics in experimental models of pain and analgesia","volume":"55","author":"Fairbanks","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tjolsen","year":"1992","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.bbr.2021.113189_bib0240","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0304-3959(77)90130-0","article-title":"The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats","volume":"4","author":"Dubuisson","year":"1977","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0304-3959(93)90098-A","article-title":"The formalin test: a validation of the weighted-scores method of behavioural pain rating","volume":"54","author":"Coderre","year":"1993","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0255","first-page":"30","article-title":"Reduced peptide bond pseudopeptide analogues of neurotensin","volume":"5","author":"Doulut","year":"1992","journal-title":"Pept. Res."},{"issue":"2","key":"10.1016\/j.bbr.2021.113189_bib0260","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(91)90819-C","article-title":"Reduced peptide bond pseudopeptide analogues of neurotensin: binding and biological activities, and in vitro metabolic stability","volume":"205","author":"Lugrin","year":"1991","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bbr.2021.113189_bib0265","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1021\/acschemneuro.9b00390","article-title":"Neurotensin analogues containing cyclic surrogates of tyrosine at position 11 improve NTS2 selectivity leading to analgesia without hypotension and hypothermia","volume":"10","author":"Eiselt","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2021.113189_bib0270","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/j.1471-4159.1984.tb05386.x","article-title":"Inactivation of neurotensin by rat brain synaptic membranes. Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase","volume":"43","author":"Checler","year":"1984","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.bbr.2021.113189_bib0275","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1471-4159.1985.tb07220.x","article-title":"Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the Arg8-Arg9 peptide bond by a metalloendopeptidase","volume":"45","author":"Checler","year":"1985","journal-title":"J. Neurochem."},{"issue":"24","key":"10.1016\/j.bbr.2021.113189_bib0280","doi-asserted-by":"crossref","first-page":"11274","DOI":"10.1016\/S0021-9258(18)67379-X","article-title":"Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes","volume":"261","author":"Checler","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bbr.2021.113189_bib0285","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1021\/ja017440q","article-title":"Influence of silaproline on peptide conformation and bioactivity","volume":"124","author":"Cavelier","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbr.2021.113189_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2020.105884","article-title":"Data set describing the in vitro biological activity of JMV2009, a novel silylated neurotensin(8-13) analog","volume":"31","author":"Besserer-Offroy","year":"2020","journal-title":"Data Brief"},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0295","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0026-895X(25)14204-1","article-title":"Neurotensin binding to extraneural and neural receptors: comparison with biological activity and structure--activity relationships","volume":"18","author":"Kitabgi","year":"1980","journal-title":"Mol. Pharmacol."},{"issue":"8","key":"10.1016\/j.bbr.2021.113189_bib0300","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1021\/acs.jmedchem.6b01848","article-title":"Use of molecular modeling to design selective NTS2 neurotensin analogues","volume":"60","author":"Fanelli","year":"2017","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.bbr.2021.113189_bib0305","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1021\/acs.jmedchem.5b00841","article-title":"Synthesis and characterization in vitro and in vivo of (l)-(Trimethylsilyl)alanine containing neurotensin analogues","volume":"58","author":"Fanelli","year":"2015","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bbr.2021.113189_bib0310","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0021-5198(19)52782-2","article-title":"Possible mechanisms of the triphasic effects of neurotensin on the rat blood pressure","volume":"31","author":"Oishi","year":"1981","journal-title":"Jpn. J. Pharmacol."},{"issue":"19","key":"10.1016\/j.bbr.2021.113189_bib0315","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/0024-3205(83)90421-6","article-title":"Release of histamine and adrenaline in vivo following intravenous administration of neurotensin","volume":"32","author":"Oishi","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2021.113189_bib0320","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0143-4179(82)90017-8","article-title":"Attenuation of triphasic blood pressure responses induced by shortening of amino acid sequences of neurotensin","volume":"2","author":"Oishi","year":"1982","journal-title":"Neuropeptides"},{"issue":"5","key":"10.1016\/j.bbr.2021.113189_bib0325","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0143-4179(84)90110-0","article-title":"Influence of histamine and prostaglandin on desensitization to neurotensin in rat blood pressure","volume":"4","author":"Oishi","year":"1984","journal-title":"Neuropeptides"},{"issue":"20","key":"10.1016\/j.bbr.2021.113189_bib0330","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/0024-3205(80)90435-X","article-title":"Compound 48\/80 inhibits neurotensin-induced hypotension in rats","volume":"27","author":"Quirion","year":"1980","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0335","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1476-5381.2011.01760.x","article-title":"Intrathecal neurotensin is hypotensive, sympathoinhibitory and enhances the baroreflex in anaesthetized rat","volume":"166","author":"Zogovic","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbr.2021.113189_bib0340","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1096\/fj.11-201822","article-title":"A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice","volume":"26","author":"Choi","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.bbr.2021.113189_bib0345","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.expneurol.2015.02.029","article-title":"Pharmacologically induced hypothermia attenuates traumatic brain injury in neonatal rats","volume":"267","author":"Gu","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2021.113189_bib0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113133","article-title":"Pharmacological hypothermia induced neurovascular protection after severe stroke of transient middle cerebral artery occlusion in mice","volume":"325","author":"Zhao","year":"2020","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.bbr.2021.113189_bib0355","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1021\/jm801072v","article-title":"Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy","volume":"52","author":"Orwig","year":"2009","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bbr.2021.113189_bib0360","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0960-894X(95)00155-M","article-title":"Reduced amide bond neurotensin 8\u201313 mimetics with potent in vivo activity","volume":"5","author":"Wustrow","year":"1995","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bbr.2021.113189_bib0365","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1124\/mol.60.6.1392","article-title":"Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2","volume":"60","author":"Richard","year":"2001","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0370","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1523\/JNEUROSCI.19-01-00503.1999","article-title":"Identification of the receptor subtype involved in the analgesic effect of neurotensin","volume":"19","author":"Dubuc","year":"1999","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2021.113189_bib0375","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/pr.118.016790","article-title":"Biased receptor signaling in drug discovery","volume":"71","author":"Kenakin","year":"2019","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.bbr.2021.113189_bib0380","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(98)00150-4","article-title":"Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception","volume":"792","author":"Tyler","year":"1998","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(01)02981-X","article-title":"Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties","volume":"919","author":"Boules","year":"2001","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2021.113189_bib0390","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3727\/000000003783992982","article-title":"The formalin test: characteristics and usefulness of the model","volume":"7","author":"Sawynok","year":"2003","journal-title":"Rev. Analg."},{"issue":"2","key":"10.1016\/j.bbr.2021.113189_bib0395","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0304-3959(90)90073-M","article-title":"The rat paw formalin test: comparison of noxious agents","volume":"40","author":"Wheeler-Aceto","year":"1990","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.bbr.2021.113189_bib0400","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0301-0082(93)90044-S","article-title":"Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model","volume":"41","author":"Porro","year":"1993","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbr.2021.113189_bib0405","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.physbeh.2011.05.015","article-title":"Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats","author":"T\u00e9treault","year":"2011","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.bbr.2021.113189_bib0410","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.bbr.2021.113189_bib0415","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1185\/030079905X65321","article-title":"Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain","author":"Devulder","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0420","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbr.2012.01.001","article-title":"Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain","volume":"229","author":"Parent","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.bbr.2021.113189_bib0425","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1096\/fj.12-225540","article-title":"Spinal NTS2 receptor activation reverses signs of neuropathic pain","volume":"27","author":"Tetreault","year":"2013","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bbr.2021.113189_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneumeth.2008.06.017","article-title":"Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: effects of morphine and rofecoxib","volume":"174","author":"Angeby-Moller","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbr.2021.113189_bib0435","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2019.01.048","article-title":"The combination of opioid and neurotensin receptor agonists improves their analgesic\/adverse effect ratio","volume":"848","author":"Eiselt","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2021.113189_bib0440","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-6-86","article-title":"PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects","author":"Kleczkowska","year":"2010","journal-title":"Mol. Pain"},{"issue":"3","key":"10.1016\/j.bbr.2021.113189_bib0445","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI70647","article-title":"Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties","volume":"124","author":"Demeule","year":"2014","journal-title":"J. Clin. Invest."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432821000772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432821000772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:23:27Z","timestamp":1778671407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432821000772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":89,"alternative-id":["S0166432821000772"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2021.113189","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2021.113189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113189"}}